Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension

被引:508
|
作者
Nagaya, N
Nishikimi, T
Okano, Y
Uematsu, M
Satoh, T
Kyotani, S
Kuribayashi, S
Hamada, S
Kakishita, M
Nakanishi, N
Takamiya, M
Kunieda, T
Matsuo, H
Kangawa, K
机构
[1] Natl Cardiovasc Ctr, Dept Internal Med, Osaka 565, Japan
[2] Natl Cardiovasc Ctr, Dept Radiol, Osaka 565, Japan
[3] Natl Cardiovasc Ctr, Res Inst, Osaka 565, Japan
基金
日本科学技术振兴机构;
关键词
D O I
10.1016/S0735-1097(97)00452-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study sought to investigate the influence of right ventricular (RV) hemodynamic variables and function on the secretion of brain natriuretic peptide (BNP) in patients with isolated RV overload. Background. Plasma BNP is known to increase in proportion to the degree of left ventricular (LV) overload. However, whether BNP secretion is also regulated in the presence of RV overload remains unknown. Methods. Plasma BNP and atrial natriuretic peptide (ANP) levels in the pulmonary artery were measured in 44 patients with RV overload: 18 with RV volume overload (RVVO) due to atrial septal defect and 26 with RV pressure overload (RVPO) due to primary or thromboembolic pulmonary hypertension. Right heart catheterization was performed in all patients. RV and LV ejection fraction, myocardial mass and volume of the four chambers were determined by using electron beam computed tomography. Results. Although both plasma BNP and ANP levels weresignificantly elevated in patients with RV overload compared with values in control subjects, plasma BNP and the BNP/ANP ratio were significantly higher in patients with RVPO than with RVVO (BNP 294 +/- 72 vs, 48 +/- 14 pg/ml; BNP/ANP 1.6 +/- 0.2 vs. 0.8 +/- 0.2, both p < 0.05). Plasma BNP correlated positively with mean pulmonary artery pressure (r = 0.73), total pulmonary resistance (r = 0.79), mean right atrial pressure (r = 0.79), RV end-diastolic pressure (r = 0.76) and RV myocardial mass (r = 0.71); it correlated negatively with cardiac output (r = -0.33) and RV ejection fraction (r = -0.71), Plasma BNP significantly decreased from 315 +/- 120 to 144 +/- 54 pg/ml with long-term vasodilator therapy (total pulmonary resistance decreased from 23 +/- 4 to 15 +/- 3 Wood U). Conclusions. Plasma BNP increases in proportion to the extent of RV dysfunction in pulmonary hypertension. (C) 1998 by the American College of Cardiology.
引用
下载
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [21] Plasma myostatin levels are related to the extent of right ventricular dysfunction in exacerbation of chronic obstructive pulmonary disease
    Ju, Chun-Rong
    Zhang, Jian-Heng
    Chen, Miao
    Chen, Rong-Chang
    BIOMARKERS, 2017, 22 (3-4) : 246 - 252
  • [22] The prognostic role of right ventricular dysfunction decreases with an increase in pulmonary hypertension
    Bugaite, J. Julija
    Gabartaite, D.
    Paleviciute, E.
    Cerlinskaite, K.
    Norvilaite, R.
    Verikas, D.
    Ziubryte, G.
    Balciunaite, G.
    Krivickiene, A.
    Motiejunaite, J.
    Zaliaduonyte-Peksiene, D.
    Zakarkaite, D.
    Mebazaa, A.
    Kavoliuniene, A.
    Celutkiene, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 318 - 319
  • [23] Right ventricular systolic function is highly dependent on left ventricular dysfunction in patients with previous myocardial infarction and high plasma brain natriuretic peptide levels
    Konishi, K.
    Dohi, K.
    Sato, Y.
    Sugiura, E.
    Sawai, T.
    Nakajima, H.
    Nakamori, S.
    Onishi, K.
    Nakamura, M.
    Ito, M.
    EUROPEAN HEART JOURNAL, 2012, 33 : 848 - 848
  • [24] Role of natriuretic peptide dysfunction in pulmonary hypertension
    Werner, F.
    Gassner, B.
    Voelker, K.
    Oberwinkler, H.
    Abesser, M.
    Schuh, K.
    Kojonazarov, B.
    Dahal, B. K.
    Schermuly, R. T.
    Kuhn, M.
    ACTA PHYSIOLOGICA, 2014, 210 : 40 - 40
  • [25] Right ventricular function in patients with advanced lung disease is reflected in plasma brain natriuretic peptide levels
    Burgess, MI
    Mogulkoc, N
    Keevil, B
    Wales, D
    Woodcock, AA
    Egan, JJ
    Ray, SG
    CIRCULATION, 1999, 100 (18) : 577 - 577
  • [26] Utility of brain natriuretic peptide to predict right ventricular dysfunction and clinical outcome in patients with acute pulmonary embolism
    Krüger, S
    Merx, MW
    Graf, J
    CIRCULATION, 2003, 108 (13) : E94 - E94
  • [27] Right ventricular dysfunction in pulmonary hypertension
    Song, Ze-Zhou
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (02) : 232 - 232
  • [28] Relationship of right ventricular diastolic function by pulsed tissue doppler imaging with brain natriuretic peptide in pulmonary hypertension
    Shiina, Yumi
    Funabashi, Nobusada
    Lee, Kwangho
    Daimon, Masao
    Sekine, Tai
    Kawakubo, Miyuki
    Sekine, Yukiko
    Takahashi, Maiko
    Yajima, Rei
    Wakatsuki, Yu
    Tanabe, Nobuhiro
    Kuriyama, Takayuki
    Komuro, Issei
    CIRCULATION, 2007, 116 (16) : 425 - 425
  • [29] Association of Intraocular Pressure Changes With Right Ventricular Diameter and Brain Natriuretic Peptide in a Case of Pulmonary Arterial Hypertension
    Sato, Chiaki
    Kaneko, Hiroki
    Kondo, Takahisa
    Takayama, Kei
    Yasuda, Shunsuke
    Terasaki, Hiroko
    JOURNAL OF GLAUCOMA, 2016, 25 (03) : E295 - E298
  • [30] High Plasma Brain Natriuretic Peptide Levels in Stable COPD without Pulmonary Hypertension or Cor Pulmonale
    Inoue, Yuzuru
    Kawayama, Tomotaka
    Iwanaga, Tomoaki
    Aizawa, Hisamichi
    INTERNAL MEDICINE, 2009, 48 (07) : 503 - 512